The Effect of Proton Pump Inhibitors on Early Implant Failure A Retrospective Cohort Study

被引:8
作者
Masri, Daya [1 ]
Retzkin, Noga [2 ]
de Souza, Sergio Luis Scombatti [3 ]
Slutzkey, Gil S. [2 ]
Tagger-Green, Nirit [2 ]
Naishlos, Sarit [4 ]
Chaushu, Liat [2 ]
机构
[1] Tel Aviv Univ, Sch Dent, Dept Oral & Maxillofacial Surg, IL-6997801 Tel Aviv, Israel
[2] Tel Aviv Univ, Sch Dent, Dept Periodontol & Implant Dent, IL-6997801 Tel Aviv, Israel
[3] Univ Sao Paulo, Fac Odontol Ribeirao Preto, Dept CTBMF & Periodontia, BR-14040904 Sao Paulo, Brazil
[4] Tel Aviv Univ, Sch Dent, Dept Pediat Dent, IL-6997801 Tel Aviv, Israel
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 02期
关键词
proton pump inhibitors; early implant failure; dental implant; DENTAL IMPLANTS; OSSEOINTEGRATION; RISK;
D O I
10.3390/medicina59020402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Maintenance of a firm and long-term stable osseointegration is the primary goal of implant dentistry. Time is used to define implant failure characteristics. Early implant failure (EIF) occurs up to one year after loading. Recent studies indicated an association between proton pump inhibitors (PPI) therapy and failure of osseointegration. The present study assessed whether the use of PPIs is a risk factor to EIF. Materials and methods: A retrospective cohort study including 687 patients and 2971 dental implants. The study group (PPIs users) comprised 17.3% (119) individuals and 18.7% (555) implants. The remaining cohort (82.7% (568) individuals and 81.3% (2416) implants) served as control. The information was taken from the patients' files. The following information was collected: age, gender, physical status, systemic diseases, HbA1C values before and after implant-supported prosthesis delivery in cases of diabetes mellitus, smoking, implant location, number of implants per individual, bone augmentation, implant brand, length and width, and EIF. EIF was defined as implant removal within a period of up to 12 months from loading. Results: EIF in PPIs vs. non-PPIs users was 19.3% vs. 14.3% (p = 0.16) at patient level and 5.4% vs. 3.5% at implant level (p = 0.03). Univariate analysis yielded factors significantly associated with PPIs use, including older age, physical status of the American Society of Anesthesiology (ASA) 3, hypertension, hyperlipidemia, diabetes mellitus, osteoporosis, cardiovascular accident (CVA), location (anterior mandible), shorter and narrower implants, and higher number of implants per individual. Multivariate analysis yielded statistically significant OR of 1.91; p = 0.01 for EIF following PPIs use and 2.3; p < 0.001 for location in anterior mandible. Conclusions: Patients and their healthcare providers are advised to carefully consider the potential risks of taking PPIs prior to dental implant surgery. Further research is needed to confirm these risks and elucidate systemic and local factors that may be involved in such outcomes.
引用
收藏
页数:9
相关论文
共 21 条
[1]   Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an invivo study on rat tibiae [J].
Al Subaie, Ahmed ;
Emami, Elham ;
Tamimi, Iskandar ;
Laurenti, Marco ;
Eimar, Hazem ;
Abdallah, Mohamed-Nur ;
Tamimi, Faleh .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2016, 43 (02) :193-203
[2]  
Albrektsson T, 1993, Aust Prosthodont J, V7 Suppl, P15
[3]   Effect of proton pump inhibitors on bone mineral density: A systematic review and meta-analysis of observational studies [J].
Aleraij, Sara ;
Alhowti, Sultan ;
Ferwana, Mazen ;
Abdulmajeed, Imad .
BONE REPORTS, 2020, 13
[4]   Proton pump inhibitor intake negatively affects the osseointegration of dental implants: a retrospective study [J].
Altay, Mehmet Ali ;
Sindel, Alper ;
Ozalp, Oznur ;
Yildirimyan, Nelli ;
Kocabalkan, Burak .
JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2019, 45 (03) :135-140
[5]   Systemic drugs that influence titanium implant osseointegration [J].
Apostu, Dragos ;
Lucaciu, Ondine ;
Lucaciu, Gheorghe Dan Osvald ;
Crisan, Bogdan ;
Crisan, Liana ;
Baciut, Mihaela ;
Onisor, Florin ;
Baciut, Grigore ;
Campian, Radu Septimiu ;
Bran, Simion .
DRUG METABOLISM REVIEWS, 2017, 49 (01) :92-104
[6]   Impact of excessive occlusal load on successfully-osseointegrated dental implants: a literature review [J].
Chang, Michael ;
Chronopoulos, Vasileios ;
Mattheos, Nikos .
JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY, 2013, 4 (03) :142-150
[7]   Medication-related dental implant failure: Systematic review and meta-analysis [J].
Chappuis, Vivianne ;
Avila-Ortiz, Gustavo ;
Araujo, Mauricio G. ;
Monje, Alberto .
CLINICAL ORAL IMPLANTS RESEARCH, 2018, 29 :55-68
[8]   Intake of Proton Pump Inhibitors Is Associated with an Increased Risk of Dental Implant Failure [J].
Chrcanovic, Bruno Ramos ;
Kisch, Jeno ;
Albrektsson, Tomas ;
Wennerberg, Ann .
INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2017, 32 (05) :1097-1102
[9]   The effect of the use of proton pump inhibitors, serotonin uptake inhibitors, antihypertensive, and anti-inflammatory drugs on clinical outcomes of functional dental implants: A retrospective study [J].
Corbella, Stefano ;
Morandi, Paolo ;
Alberti, Alice ;
Morandi, Benedetta ;
Francetti, Luca .
CLINICAL ORAL IMPLANTS RESEARCH, 2022, 33 (08) :834-843
[10]   The STROBE guidelines [J].
Cuschieri, Sarah .
SAUDI JOURNAL OF ANAESTHESIA, 2019, 13 :31-34